findmyKOL
Clinical trialNCT05998759RecruitingPhase 2Interventional

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

SponsorBeijing HospitalEnrollment296Connective Tissue DiseasesThrombocytopenia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Anhui Medical College

    Hefei, Anhui, China

    Recruiting
  • the First Affiliated Hospital of China University of Science and Technology (anhui Provincial)

    Hefei, Anhui, China

    Recruiting
  • Beijing Hospital

    Beijing, Beijing Municipality, China

    Fang Wang, MD.Like Zhao, MD.Min Feng, MD.Min Wang, MD.Qian Wang, MD.Ru Feng, MD.Yanxiang Luo, MD.Yingjuan Chen, MD.Zhe Chen, MD.
    Recruiting
  • Peking University People'S Hospital

    Beijing, Beijing Municipality, China

    Recruiting
  • Peking University Third Hospital

    Beijing, Beijing Municipality, China

    Recruiting
  • First Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

    Recruiting
  • Guangdong Provincial People'S Hospital

    Guangzhou, Guangdong, China

    Recruiting
  • the First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

    Recruiting
  • Wuhan Union Hospital, China

    Wuhan, Hubei, China

    Recruiting
  • Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

    Recruiting
  • Xiangya Hospital of Central South University

    Changsha, Hunan, China

    Recruiting
  • the Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, China

    Recruiting
  • First Hospital of China Medical University

    Shenyang, Liaoning, China

    Recruiting
  • Shandong Provincial Hospital

    Jinan, Shandong, China

    Recruiting
  • Changhai Hospital

    Shanghai, Shanghai Municipality, China

    Recruiting
  • Renji Hospital

    Shanghai, Shanghai Municipality, China

    Recruiting
  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China

    Recruiting
  • West China Hospital

    Chengdu, Sichuan, China

    Recruiting
  • Institute of Hematology & Blood Diseases Hospital

    Tianjin, Tianjin Municipality, China

    Recruiting
  • Tianjin First Central Hospital

    Tianjin, Tianjin Municipality, China

    Recruiting
  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

    Recruiting
  • People'S Hospital of Xinjiang Uygur Autonomous Region

    Ürümqi, Xinjiang Uygur Autonomous Region, China

    Recruiting
  • the First People'S Hospital of Yunnan

    Kunming, Yunnan, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Dec 2023
Primary completion
31 Dec 2025
Completion
31 Dec 2025
Last update posted
6 May 2025
Registered enrollment
296
Registry id
NCT05998759

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.